Nicox S.A. (NICXF)

USD 0.25

(0.0%)

Revenue Summary of Nicox S.A.

  • Nicox S.A.'s latest annual revenue in 2023 was 257 Thousand EUR , down -95.42% from previous year.
  • Nicox S.A.'s latest quarterly revenue in 2023 FY was 257 Thousand EUR , down -95.42% from previous quarter.
  • Nicox S.A. reported a annual revenue of 5.61 Million USD in annual revenue 2022, down -42.49% from previous year.
  • Nicox S.A. reported a annual revenue of 9.75 Million USD in annual revenue 2021, down -44.72% from previous year.
  • Nicox S.A. reported a quarterly revenue of 2.77 Million USD for 2023 Q2, up 194.92% from previous quarter.
  • Nicox S.A. reported a quarterly revenue of 939.9 Thousand EUR for 2023 Q1, down -67.81% from previous quarter.

Annual Revenue Chart of Nicox S.A. (2023 - 2001)

Historical Annual Revenue of Nicox S.A. (2023 - 2001)

Year Revenue Revenue Growth
2023 257 Thousand EUR -95.42%
2022 5.61 Million USD -42.49%
2021 9.75 Million USD -44.72%
2020 17.64 Million USD 90.33%
2019 9.27 Million USD 96.56%
2018 4.71 Million EUR -68.72%
2017 15.08 Million EUR 94150.0%
2016 16 Thousand EUR -76.12%
2015 67 Thousand EUR -98.88%
2014 5.98 Million EUR 1271.79%
2013 436 Thousand EUR -94.27%
2012 7.61 Million EUR 0.0%
2011 - EUR -100.0%
2010 7.42 Million EUR 563.36%
2009 1.11 Million EUR -66.72%
2008 3.36 Million EUR -83.7%
2007 20.62 Million EUR 114.12%
2006 9.63 Million EUR 47.52%
2005 6.52 Million EUR 452.28%
2004 1.18 Million EUR -15.81%
2003 1.4 Million EUR -74.32%
2002 5.46 Million EUR 0.0%
2001 - EUR 0.0%

Peer Revenue Comparison of Nicox S.A.

Name Revenue Revenue Difference
Bioxytran, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 98.371%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 98.803%
Intellipharmaceutics International Inc. 65.72 Thousand USD -291.005%
Evofem Biosciences, Inc. 18.21 Million USD 98.589%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.791%
Propanc Biopharma, Inc. - USD -Infinity%
Marizyme, Inc. 645.81 Thousand USD 60.205%
Genus plc 668.8 Million USD 99.962%
Pharming Group N.V. 245.31 Million USD 99.895%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -159.612%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 37.342%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -234.805%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -550.337%
ONE Bio Corp. 52.29 Million USD 99.509%
RVL Pharmaceuticals plc 49.72 Million USD 99.483%
Mesoblast Limited 5.9 Million USD 95.646%
MultiCell Technologies, Inc. 49.32 USD -520986.78%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.132%
Genscript Biotech Corporation 839.52 Million USD 99.969%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -1358.487%
Biomind Labs Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 53.919%
Oncotelic Therapeutics, Inc. 70 Thousand USD -267.143%
Skye Bioscience, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -239.39%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 60.972%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -425.562%
Q BioMed Inc. 284.35 Thousand USD 9.619%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.998%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.823%
Enzolytics Inc. 52.79 Thousand USD -386.779%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 57.767%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.979%
Northwest Biotherapeutics, Inc. 1.93 Million USD 86.698%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -25625.726%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -83.255%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 58.373%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 74.241%
Capstone Therapeutics Corp. 48.35 Million USD 99.469%
Kadimastem Ltd - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 98.46%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -8.641%
Regen BioPharma, Inc. 236.56 Thousand USD -8.641%
Affymax, Inc. 1.36 Million USD 81.227%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 96.7%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 45.75%
SYBLEU INC 11.69 Thousand USD -2097.332%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -1876.923%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -550.073%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 92.282%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 96.144%
IntelGenx Technologies Corp. 1.03 Million USD 75.265%
Gelesis Holdings, Inc. 25.76 Million USD 99.003%
CSL Limited 14.8 Billion USD 99.998%
Cellectis S.A. 755 Thousand USD 65.96%